USHSTAT

Welcome to the Brand page for “USHSTAT”, which is offered here for In the statement, page 2, line 6, 4-12-2009, is deleted and 12-4-2009, should be inserted.;gene therapy products, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and usher's disease; biochemical preparations for medical purposes, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations;enzymes for scientific and research purposes; chemicals for use in industry and science, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science;medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes;scientific and medical research and development; genetic engineering services, biotechnology services, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products;.

Its status is currently believed to be active. Its class is unavailable. “USHSTAT” is believed to be currently owned by “Oxford BioMedica plc”.